Device Servicing And Remanufacturing: US FDA, Stakeholders Try To Draw Distinction
Executive Summary
US FDA’s device center in concert with third-party servicers and original equipment manufacturers are working toward consensus on how to differentiate medtech "servicing" from "remanufacturing" activities. Progress was made at a recent workshop in laying out ways that better training and more data sharing will help.